EFG
GILD icon

Everhart Financial Group’s Gilead Sciences GILD Stock Holding History

Everhart Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
9,646
-1,593
-14% -$210K 0.08% 139
2026
Q1 		$1.57M Buy
11,239
+2,464
+28% +$345K 0.13% 102
2025
Q4 		$1.08M Buy
8,775
+1,425
+19% +$173K 0.1% 142
2025
Q3 		$816K Buy
7,350
+2,165
+42% +$246K 0.08% 179
2025
Q2 		$575K Buy
5,185
+1,143
+28% +$122K 0.07% 210
2025
Q1 		$453K Buy
4,042
+1,450
+56% +$150K 0.06% 224
2024
Q4 		$239K Buy
+2,592
New +$233K 0.05% 283

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Everhart Financial Group's GILD Position: Q2 2026 in Review

Everhart Financial Group reduced its Gilead Sciences (GILD) stake by 14% in Q2 2026, selling an estimated $210K and leaving 9,646 shares worth $1.22M. The position accounts for 0.08% of the portfolio, ranked #139.

Everhart Financial Group first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.57M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Everhart Financial Group held 9,646 shares of Gilead Sciences worth $1.22M as of Q2 2026.
  • Everhart Financial Group sold 1,593 Gilead Sciences shares in Q2 2026, an estimated $210K.
  • Gilead Sciences made up 0.08% of Everhart Financial Group's portfolio in Q2 2026, its #139 holding.
  • Everhart Financial Group first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Everhart Financial Group's Gilead Sciences position peaked at $1.57M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.